While HIMS reported impressive revenue growth of 69% to $1.48 billion in 2024 and achieved its first full year of GAAP profitability with a net income of $126.0 million , the GLP-1 segment was a key driver of this momentum
Two of the most popular and effective peptides for this purpose are Sermorelin and CJC-1295
As of Summer 2023, Wegovy (semaglutide) and Saxenda (liraglutide) are approved for weight loss
O., Legha, A., Littlewood, C., Chesterton, L
Lung health: It has demonstrated lung-protective activities in animal models of fibrotic lung disease, COPD, acute lung injury, and asthma, where it was found to reduce inflammation and fibrosis [2,1113]